Work

Relationship between three commonly used non‐invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non‐alcoholic steatohepatitis

Year: 2018

Type: article

Source: Liver International

DOI: 10.1111/liv.13974

Authors: Naga Chalasani, Manal F. Abdelmalek, Rohit Loomba, Kris V. Kowdley, Arthur J. McCullough, Srinivasan Dasarathy, Brent A. Neuschwander‐Tetri, Norah Terrault, Beatrice Ferguson, Reshma Shringarpure, David Shapiro, Arun J. Sanyal

Institutions: Indiana University Indianapolis, Indiana University School of Medicine, Duke University, Duke Medical Center, University of California San Diego, Swedish Medical Center, Cleveland Clinic, Saint Louis University, University of California, San Francisco, Intercept Pharmaceuticals (United States), Virginia Commonwealth University, Virginia Commonwealth University Medical Center

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Intercept Pharmaceuticals, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: Center for Clinical and Translational Research, Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)

OpenAlex ID: W2915871580

FWCI: 6.431

Cites: 34

Cited by: 58

Related to: 10